MOG and myeloid sarcoma: The human antibodies against MOG from immunoglobulin-G subclasses (MOG-IgG) have been recently associated with a new subgroup of neurological autoimmune diseases, with distinct clinical characteristics and prognosis from multiple sclerosis (MS) and aquaporin-4-IgG positive neuromyelitis optica spectrum disorders (NMOSD).